Hayes DF - Search Results

1

The Role of c-erbB-2 as a predictive factor in breast cancer.

Yamauchi H, Stearns V, Hayes DF. Yamauchi H, et al. Among authors: hayes df. Breast Cancer. 2001;8(3):171-83. doi: 10.1007/BF02967506. Breast Cancer. 2001. PMID: 11668238 Review.

2

Angiogenesis and breast cancer.

Hayes DF. Hayes DF. Hematol Oncol Clin North Am. 1994 Feb;8(1):51-71. Hematol Oncol Clin North Am. 1994. PMID: 7512088 Review.

3

Treatment of metastatic breast cancer: present and future prospects.

Hayes DF, Henderson IC, Shapiro CL. Hayes DF, et al. Semin Oncol. 1995 Apr;22(2 Suppl 5):5-19; discussion 19-21. Semin Oncol. 1995. PMID: 7537913 Review.

4

Tumor markers for breast cancer.

Hayes DF. Hayes DF. Ann Oncol. 1993 Dec;4(10):807-19. doi: 10.1093/oxfordjournals.annonc.a058385. Ann Oncol. 1993. PMID: 8117599 Free article. Review.

5

Serum (circulating) tumor markers for breast cancer.

Hayes DF. Hayes DF. Recent Results Cancer Res. 1996;140:101-13. doi: 10.1007/978-3-642-79278-6_12. Recent Results Cancer Res. 1996. PMID: 8787054 Review.

6

Prediction of response to antiestrogen therapy in advanced breast cancer patients by pretreatment circulating levels of extracellular domain of the HER-2/c-neu protein.

Yamauchi H, O'Neill A, Gelman R, Carney W, Tenney DY, Hösch S, Hayes DF. Yamauchi H, et al. Among authors: hayes df. J Clin Oncol. 1997 Jul;15(7):2518-25. doi: 10.1200/JCO.1997.15.7.2518. J Clin Oncol. 1997. PMID: 9215820

7

Circulating tumor markers in breast cancer: accepted utilities and novel prospects.

Stearns V, Yamauchi H, Hayes DF. Stearns V, et al. Among authors: hayes df. Breast Cancer Res Treat. 1998;52(1-3):239-59. doi: 10.1023/a:1006137619153. Breast Cancer Res Treat. 1998. PMID: 10066086 Review.

8

Assessing the clinical impact of prognostic factors: when is "statistically significant" clinically useful?

Hayes DF, Trock B, Harris AL. Hayes DF, et al. Breast Cancer Res Treat. 1998;52(1-3):305-19. doi: 10.1023/a:1006197805041. Breast Cancer Res Treat. 1998. PMID: 10066089 Review.

9

Antibody dependent cellular phagocytosis (ADCP) and antibody dependent cellular cytotoxicity (ADCC) of breast cancer cells mediated by bispecific antibody, MDX-210.

Watanabe M, Wallace PK, Keler T, Deo YM, Akewanlop C, Hayes DF. Watanabe M, et al. Among authors: hayes df. Breast Cancer Res Treat. 1999 Feb;53(3):199-207. doi: 10.1023/a:1006145507567. Breast Cancer Res Treat. 1999. PMID: 10369066

10

A pilot trial assessing the efficacy of paroxetine hydrochloride (Paxil) in controlling hot flashes in breast cancer survivors.

Stearns V, Isaacs C, Rowland J, Crawford J, Ellis MJ, Kramer R, Lawrence W, Hanfelt JJ, Hayes DF. Stearns V, et al. Among authors: hayes df. Ann Oncol. 2000 Jan;11(1):17-22. doi: 10.1023/a:1008382706068. Ann Oncol. 2000. PMID: 10690382 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

483 results

Search Page

Filters